Secondly, while we tried to eliminate all systemic inflammatory conditions that might influence the levels of CCL3 by using the most important inflammatory markers and keeping only participants with healthy values, we could not exclude a possible infection or inflammation in one or more patients, which constitutes the second major limitation of our study. The gene discussed is CCL3; the disease is infection.